Food and Drug Law Journal
| 短名 | Food. Drug. Law. J. |
| Journal Impact | 0.26 |
| 国际分区 | PHARMACOLOGY & PHARMACY(Q4) |
| 期刊索引 | SCI Q4中科院 4 区 |
| ISSN | 1064-590X |
| h-index | 23 |
| 国内分区 | 医学(4区)医学食品科技(4区)医学法学(4区)医学营养学(4区)医学药学(4区) |
《食品药品法杂志》是一份经过同行评审的季刊，专门分析影响美国食品药品监督管理局 (FDA) 和相关机构和当局监管的行业的立法、法规、法院判决和公共政策，包括开发、药物、医疗器械、生物制品、食品、膳食补充剂、化妆品、兽医、烟草和大麻衍生产品的制造、营销和使用。基于 70 多年的学术讨论，自 2015 年以来，该杂志以合作伙伴关系出版与乔治城大学法律中心和奥尼尔国家和全球卫生法研究所合作。所有成员都可以在线访问该期刊。每个成员组织和大多数个人会员（政府、学生和退休会员除外）都会收到一份印刷期刊订阅。
期刊主页| 涉及主题 | 业务生物政治学医学经济法学药理学心理学计算机科学精神科数学社会学药品哲学化学环境卫生管理病理风险分析（工程）营销 |
| 出版信息 | 出版商: Food and Drug Law Institute，出版周期: Quarterly，期刊类型: journal |
| 基本数据 | 创刊年份: 2021，原创研究文献占比: 100.00%，自引率:33.30%， Gold OA占比: 0.00% |
| 平均审稿周期 | 网友分享经验：>36周，或约稿 |
| 平均录用比例 | 网友分享经验：容易 |
期刊引文格式
这些示例是对学术期刊文章的引用，以及它们应该如何出现在您的参考文献中。
并非所有期刊都按卷和期组织其已发表的文章，因此这些字段是可选的。有些电子期刊不提供页面范围，而是列出文章标识符。在这种情况下，使用文章标识符而不是页面范围是安全的。
只有1位作者的期刊
有2位作者的期刊
有3位作者的期刊
有5位以上作者的期刊
书籍引用格式
以下是创作和编辑的书籍的参考文献的示例。
学位论文引用格式
网页引用格式
这些示例是对网页的引用，以及它们应该如何出现在您的参考文献中。
专利引用格式
最新文章
FDA Regulation of Stem Cell Therapies: Using a Stem Cell Fraud Strike Force to Separate Fact from Fiction
2020-1-1
Life, Liberty, [and the Pursuit of Happiness]: Medical Marijuana Regulation in Historical Context
2019-1-1
Have a (Non-Energy) Drink on Me - Modifying the Laws Regarding Energy Drinks in Australia
2019-1-1
European Novel Foods Policy at a Critical Juncture:Drawing lessons for future Novel Food Governancethrough a retrospective examination of Regulation 258/97
2017-9-1
Evolution Along the Government-Governance Continuum: FDA's Orphan Products and Fast Track Programs as Exemplars of "What Works" for Innovation and Regulation
2009-11-1
Emerging product categories in India: a regulatory view.
2009-1-1
Encouraging research and development of pediatric medical devices through legislative and regulatory action: the Pediatric Medical Device Safety and Improvement Act of 2007 in context.
2009-1-1
Dietary supplement adverse event reports: review and analysis.
2009-1-1
Country of origin labeling: history and public choice theory.
2009-1-1
The family smoking prevention and tobacco control act: an overview.
2009-1-1
Crises, congress and cognitive biases: a crititical examination of food and drug legislation in the United States.
2009-1-1
FDA regulation of tobacco: blessing or curse for FDA professionals?
2009-1-1
Legal developments in the enforcement of food and drug law.
2008-1-1
To ban or not to ban--that is the question: the constitutionality of a moratorium on consumer drug advertising.
2008-1-1
Examining mandatory HPV vaccination for all school-aged children.
2007-1-1
Unlabeled drug samples and the learned intermediary: the case for drug company liability without preemption.
2007-1-1
Potential pathways for abbreviated approval of generic biologics under existing law and proposed reforms to the law.
2007-1-1
Strategy for surveillance of adverse drug events.
2007-1-1
Disclaimers in dietary supplement print advertising: the bodybuilding category as a model case for change.
2007-1-1
New FDA guidance documents.
2007-1-1
U.S. postmarketing pharmacovigilance compliance in the midst of regulatory uncertainty.
2007-1-1
What a Food and Drug lawyer should know about the Medicare Modernization Act.
2004-1-1
Guidelines on gifts to physicians from industry: An update
2001-5-5
Ethical issues in the patenting of medical procedures
1998-7-24
Clinical research center for rare diseases Villa Camozzi
1994-1-1
Reporting adverse drug and medical device events: Report of the AMA's council on ethical and judicial affairs
1994-1-1
Regulating the safety of implants. 1. Government regulation
1991-1-1
帮你贴心管理全部的文献
研飞ivySCI，高效的论文管理
投稿经验分享
分享我的经验，帮你走得更远